In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse
References (20)
- et al.
Interferon-gamma: a key master in the immune system
Current Opinion Immunol.
(1988) - et al.
Spontaneous T-cell lymphokine production and enhanced macrophage 1a expression and tumoricidal activity in MRL-lpr mice
Clin Immunol Immunopathol
(1982) - et al.
Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-gamma
Lancet
(1990) - et al.
Spontaneous murine lupus-like syndrome
J Exp Med
(1978) - et al.
In vivo treatment of experimental autoimmune uveoretinitis with monoclonal antibody to gamma-interferon
Ocular Immunol Today (Supplement)
(1990) - et al.
Tumor necrosis factor and IL-1 in New Zealand Black/White mice
J Immunol
(1989) - et al.
Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice
J Clin Invest
(1991) - et al.
Tumour necrosis factor/cachectin plays a key role in autoimmune pulmonary inflammation in lupus-prone mice
Clin Exp Immunol
(1991) - et al.
A convenient and rapid cytopathic effect inhibition assay for Interferon
Methods Enzymol
(1981) Cytokines in the pathophysiology of systemic lupus erythematosus
Autoimmunity
(1990)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1992 Published by Elsevier B.V.